Work

Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma.

Year: 2016

Type: other

Abstract: Dr Geschwind has received grant support from Philips Healthcare, BTG, Guerbet, Boston Scientific, Threshold, and the National Institutes of Health. He has been a consultant to Philips Healthcare, BTG, Terumo, Guerbet, Bayer HealthCare, and Boston Scientific. Dr Chapiro has received grant support from the German-Israeli Foundation for Scientific Research and Development, the Rolf W. Gunther Foundation for Radiological Sciences, Philips Healthcare, and Berlin Institute of Health.

Source: PubMed

Authors: Jean-Francois H Geschwind, Julius Chapiro

Institution: Yale University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2508309346

Cites: 7

Cited by: 9

Related to: 10